2bPrecise specializes in delivering advanced point-of-care solutions that enhance the practice of precision medicine. Their platform integrates pharmacogenomics and genomic science to provide healthcare professionals with critical insights into patient care. By facilitating access to genetic profiles, drug-gene interactions, and tumor profiles, 2bPrecise enables clinicians to make informed decisions that can lead to more effective and personalized treatment plans. The technology addresses common clinical challenges, such as identifying suitable therapies for patients who do not respond to standard treatments and managing complex diagnostic dilemmas.

The 2bPrecise platform is designed to be modular and scalable, allowing healthcare organizations to implement functionalities based on their specific needs and priorities. It emphasizes data management and workflow efficiency, ensuring that valuable genetic information is readily accessible within electronic health records (EHRs). This integration helps eliminate inefficiencies, such as the need to chase down test results locked in PDFs or external systems, thereby streamlining oncology workflows and enhancing patient care. Overall, 2bPrecise's innovative approach aims to transform the landscape of precision medicine by making critical data available at the point of care.

United States

The 2bPrecise platform integrate genomic data withclinical knowledge and genomic research to identify relevant information for clinical care.

2bPrecise

Company Details